Sign In
Buy PRCT
$16.69
-0.86 (-4.90%)
At Close: Jul 24, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
04:59pm, Thursday, 05'th Mar 2026
NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ: PRCT). Such investors ar
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES
06:50pm, Wednesday, 04'th Mar 2026
Procept BioRobotics reported one set of numbers to investors -- the actual figures told a different story NEW YORK,, March 4, 2026 /PRNewswire/ -- Investors in Procept BioRobotics (NASDAQ: PRCT) lost
PROCEPT BioRobotics Corporation (PRCT) Analyst/Investor Day Transcript
04:42pm, Wednesday, 04'th Mar 2026
PROCEPT BioRobotics Corporation (PRCT) Analyst/Investor Day Transcript
DNB Asset Management AS Buys Shares of 31,719 PROCEPT BioRobotics Corporation $PRCT
06:28am, Wednesday, 04'th Mar 2026
DNB Asset Management AS bought a new position in shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) in the undefined quarter, according to its most recent 13F filing with the SEC. The fund bough
Lost Money on PROCEPT BioRobotics Corporation (PRCT)? Contact Levi & Korsinsky About Fraud Investigation
03:44pm, Tuesday, 03'rd Mar 2026
New York, New York--(Newsfile Corp. - March 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PROCEPT BioRobotics Corporation ("PROCEPT BioRobotics Corporation
Artisan Partners Limited Partnership Buys 378,844 Shares of PROCEPT BioRobotics Corporation $PRCT
04:26am, Saturday, 28'th Feb 2026
Artisan Partners Limited Partnership grew its stake in shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) by 38.4% during the third quarter, according to the company in its most recent 13F filin
Ademi LLP Investigates Claims of Securities Fraud against PROCEPT BioRobotics Corporation
04:55pm, Thursday, 26'th Feb 2026
MILWAUKEE, Feb. 26, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against PROCEPT BioRobotics (NASDAQ: PRCT). The investigation results from inaccurate statements PR
PROCEPT BioRobotics Corporation (PRCT) Q4 2025 Earnings Call Transcript
12:47pm, Thursday, 26'th Feb 2026
PROCEPT BioRobotics Corporation (PRCT) Q4 2025 Earnings Call Transcript
Robotics Play Procept Biorobotics Plummets On Hard-To-Stomach Update
10:02am, Thursday, 26'th Feb 2026
Procept Biorobotics stock crashed Thursday on a hard-to-stomach update that included light fourth-quarter sales and a 2026 guidance cut.
PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth
07:55am, Thursday, 26'th Feb 2026
NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformati
PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why
07:04am, Thursday, 26'th Feb 2026
PROCEPT BioRobotics Corp. (NASDAQ: PRCT) shares are down during Thursday's premarket session following the company's recent financial results and updates on its revenue guidance.
PROCEPT BioRobotics Corporation (PRCT) Reports Q4 Loss, Lags Revenue Estimates
08:25pm, Wednesday, 25'th Feb 2026
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.35 per share a year ago.
PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance
04:02pm, Wednesday, 25'th Feb 2026
SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tr
PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
04:03pm, Monday, 23'rd Feb 2026
SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing tran
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives $53.40 Average PT from Analysts
01:46am, Tuesday, 10'th Feb 2026
PROCEPT BioRobotics Corporation (NASDAQ: PRCT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the thirteen ratings firms that are presently covering the stock, Marketbea
